+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Eczema Drug"

OPZELURA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

OPZELURA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
From
Hand Eczema (HE) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Hand Eczema (HE) - Epidemiology Forecast - 2032

  • Report
  • July 2022
  • 98 Pages
  • Global
From
From
Atopic Dermatitis (AD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Atopic Dermatitis (AD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Eczema Therapeutics Market 2024-2028 - Product Thumbnail Image

Eczema Therapeutics Market 2024-2028

  • Report
  • April 2024
  • 172 Pages
  • Global
From
From
From
From
Atopic Dermatitis: Epidemiology Forecast to 2027 - Product Thumbnail Image

Atopic Dermatitis: Epidemiology Forecast to 2027

  • Report
  • November 2018
  • 30 Pages
  • Global
From
Loading Indicator

The Eczema Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Eczema drugs are used to treat the symptoms of eczema, a chronic skin condition characterized by red, itchy, and inflamed skin. These drugs are typically topical creams, ointments, and lotions, and may contain corticosteroids, calcineurin inhibitors, and other active ingredients. In addition to treating the symptoms of eczema, these drugs may also help to reduce the risk of infection and improve the overall quality of life for those affected by the condition. Some companies in the Eczema Drug market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Mylan. Show Less Read more